Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Induction chemotherapy with daunorubicin, cytarabine, and gemtuzumab ozogamicin in acute myeloid leukemia

Induction chemotherapy with daunorubicin, cytarabine, and gemtuzumab ozogamicin in acute myeloid leukemia. Case Studies in Leukemia. 2002.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.